Flora Growth Corp Stock Price, News & Analysis

Clifford Starke, an investor in Flora Growth Corp. (FLGC), has increased his holdings in the company. On August 14, 2024, FLGC shareholders approved the issuance of 1,028,665 stock appreciation rights (SARs) to Starke on December 15, 2023, and an additional 575,319 SARs on August 14, 2024. These SARs vest in 12 equal installments, subject to share price criteria, with a ten-year term. Following this acquisition, Starke's fully-diluted ownership in FLGC increased from approximately 10.03% to 16.44% of outstanding common shares. Starke may acquire or dispose of FLGC securities in the future, depending on market conditions and other factors.

Flora Growth Corp. (NASDAQ: FLGC) has announced significant changes to its Board of Directors. Harold Wolkin, with over 30 years of finance sector experience, has been appointed as an independent director and will chair the Audit Committee. Wolkin's extensive background includes roles at BMO Capital Markets and Dundee Capital Markets, as well as current board positions at several public companies. Additionally, Clifford Starke, the company's CEO, has been named Chairman of the Board.

Wolkin's appointment is expected to strengthen Flora's financial strategy and governance as it expands globally. His expertise in investment banking and corporate governance, along with his CFA designation and academic background in economics, positions him as a valuable addition to Flora's leadership team.

Flora Growth Corp. (NASDAQ: FLGC) has unveiled a new corporate branding initiative, including a new logo and website. This transformation reflects the company's commitment to innovation and its vision of setting a global standard for consumer products and pharmaceuticals. The new logo features a modern design symbolizing Flora's connection to nature, while the color scheme represents health and future prosperity.

CEO Clifford Starke stated that this rebranding marks a new chapter for Flora as it aims to become the leading NASDAQ small-cap cannabis company. The redesigned website offers an improved user experience with enhanced product information, a comprehensive resource on the company's portfolio, and an updated investor relations section. This rebranding effort follows the company's restructuring and signals a focus on driving growth through organic expansion and strategic acquisitions.

Flora Growth Corp. (NASDAQ: FLGC) held its 2024 Annual and Special Meeting of Shareholders, where several key proposals were voted on. Shareholders elected four directors to the Board and reappointed Davidson & Company LLP as auditors. They also approved an amendment to increase the number of shares issuable under the 2022 Incentive Compensation Plan from 950,000 to 2,500,000. Additionally, shareholders approved the grant of stock appreciation rights to the CEO and CFO, and the issuance of 635,363 shares to acquire the minority interest of TruHC Pharma GmbH. All proposals passed with significant majority support, demonstrating shareholder confidence in the company's direction and governance.

Flora Growth Corp. (NASDAQ: FLGC) reported Q2 2024 financial results, highlighting strategic acquisitions and partnerships. Key developments include:

1. Acquisition of TruHC Pharma GmbH in Germany for $6.4 million in shares.

2. Acquisition of Australian Vaporizers for $0.7 million in shares.

3. Joint venture with Althea Group Holdings to enter the U.S. beverages market.

4. Q2 2024 financial highlights:

• Net loss of $2.7 million, improved 94% year-over-year
• Cash used in operations of $0.3 million, improved 91% year-over-year
• Total operating expenses of $6.7 million
• Adjusted EBITDA loss of $2.8 million

The company also launched new products, entered distribution partnerships, and listed on the Frankfurt Stock Exchange.

Flora Growth Corp. (NASDAQ: FLGC) celebrates National CBD Day, highlighting the CBD industry's rapid growth and increasing acceptance. The market is projected to surpass $16 billion with a 40% CAGR since 2021. Key points include:

• Over 325,000 individuals employed in the U.S. CBD sector
• Widespread retail availability, including specialty stores and mainstream chains
• Increasing favorable regulations across states

Flora Growth leverages its JustCBD brand to contribute to the industry's growth, focusing on high-quality CBD products. CEO Clifford Starke emphasizes the company's alignment with the industry's trajectory of serving consumers, job creation, and advocating for sensible regulations.

Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) has announced its listing on the Frankfurt Stock Exchange (FSE) under the symbol '7301'. This strategic move aims to increase trading liquidity and facilitate investment from European investors. The FSE, one of the world's largest organized exchange-trading markets, offers Flora access to its electronic trading platform, XETRA, which is directly linked to major European financial hubs.

CEO Clifford Starke emphasized that this listing provides a pathway for new European investors to gain exposure to the company, in addition to enhancing liquidity and trading. The FSE's reach extends to key financial centers such as Switzerland, Luxembourg, Lichtenstein, and Monaco, potentially broadening Flora's investor base.

Flora Growth Corp. (NASDAQ: FLGC) has announced the launch of two new gummy products under its JustCBD brand. The new offerings include JustCBD+ Calm Gaba & L-Theanine Mixed Berry Gummies for stress management and relaxation, and JustCBD+ Sleep Magnesium and Melatonin Raspberry Gummies for improved sleep quality.

The Calm gummies combine Gaba and L-Theanine to help users manage stress, while the Sleep gummies utilize Magnesium and Melatonin to promote faster and deeper sleep. Both products feature appealing flavors to enhance the user experience. CEO Clifford Starke emphasized that these new products align with the company's mission to provide high-quality, effective solutions to enhance customers' lives.

Flora Growth Corp. (NASDAQ: FLGC) has completed the acquisition of Australian Vaporizers Pty The deal involved exchanging 550,000 Flora common shares, valued at $0.7 million based on the closing price on June 3, 2024. The transaction closed on June 4, 2024. Australian Vaporizers, founded in 2010, is among Australia's largest online retailers of vaporizers and related accessories. The company has sold over 92,000 units to more than 30,000 active customers through B2B and direct consumer channels. Flora's CEO, Clifford Starke, highlighted that the acquisition will enhance the company's bottom line and create synergies with existing brands, particularly Vessel Brand products in Australia.